Medicine and Dentistry
Primary Biliary Cirrhosis
90%
Chronic Hepatitis B
83%
Liver Transplantation
62%
Hazard Ratio
59%
Ursodeoxycholic Acid
52%
Hepatocellular Carcinoma
44%
Systematic Review
39%
Hepatitis B Antigen
39%
Hepatitis B(e) Antigen
38%
Hepatitis B Virus
36%
Liver Cirrhosis
35%
Clinical Trial
30%
Cholangiocarcinoma
29%
Event Free Survival
29%
Peginterferon
29%
Obeticholic Acid
29%
Placebo
26%
Fibrosis
25%
Alanine Aminotransferase
24%
Alkaline Phosphatase
24%
Recurrent Disease
23%
Overall Survival
21%
Hepatitis B
21%
Retrospective Cohort Study
20%
Meta-Analysis
19%
Congenital Diaphragm Hernia
19%
Alagille Syndrome
19%
Colorectal Carcinoma
19%
Autoimmune Hepatitis
19%
Hepatitis C Virus
18%
Cohort Analysis
18%
Graft Failure
17%
Diseases
17%
Aspartate Aminotransferase
15%
Infection
15%
Prevalence
14%
Randomized Controlled Trial
14%
Decompensated Liver Cirrhosis
14%
Graft Survival
13%
Bile Acid
13%
Liver Disease
12%
Treatment Response
12%
Bilirubin
12%
Transaminase
12%
Prognostic Factor
11%
Platelet
11%
Disease Course
11%
Diabetes Mellitus
11%
Liver Fibrosis
11%
Hepatectomy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Biliary Cirrhosis
100%
Chronic Hepatitis B
83%
Hepatitis B(e) Antigen
57%
Hepatitis B Antigen
51%
Peginterferon
49%
Ursodeoxycholic Acid
46%
Cohort Study
36%
Obeticholic Acid
32%
Prevalence
32%
Event Free Survival
29%
Placebo
29%
Liver Disease
28%
Diseases
28%
Infection
28%
Liver Cirrhosis
27%
Hepatitis C Virus
25%
Alkaline Phosphatase
23%
Fibrosis
22%
HIV
22%
Interferon
22%
Hepatitis B Virus
21%
Maralixibat
19%
Alagille Syndrome
19%
Immunogenicity
19%
Chronic Hepatitis C
19%
Colorectal Carcinoma
19%
Entecavir
19%
Autoimmune Hepatitis
19%
Clinical Trial
19%
Alanine Aminotransferase
15%
Aspartate Aminotransferase
15%
Overall Survival
14%
Alpha Interferon
13%
Bile Acid
13%
Hepatitis B
13%
Liver Cell Carcinoma
12%
Hepatitis C
12%
Aminotransferase
12%
Disease Course
11%
Bilirubin
11%
Diabetes Mellitus
11%
Liver Fibrosis
11%
Polyethylene Glycol
11%
Virus Vaccine
9%
Breast Cancer
9%
Hepatitis B Core Antigen
9%
Beclometasone
9%
Genetic Risk
9%
Prothrombin
9%
Vaccine Development
9%
Immunology and Microbiology
Hepatitis B
48%
Primary Biliary Cirrhosis
30%
Hepatitis B Antigen
28%
HBsAg
28%
Human Immunodeficiency Virus
25%
Hepatitis B(e) Antigen
25%
Liver Transplantation
21%
Interferon Type I
20%
Alanine
20%
Pegylated Interferon
19%
COVID-19
19%
Booster Dose
19%
Immunogenicity
19%
Autoimmune Hepatitis
19%
Hepatitis C Virus
19%
Prevalence
19%
Overall Survival
16%
HBV DNA
14%
Hepatitis B Core Antibody
10%
Hepatitis C
9%
HBcAg
9%
Hepatitis A
9%
Virus Vaccine
9%
Toll-Like Receptor
9%
Alpha Fetoprotein
9%
Enterohepatic Circulation
9%
Event Free Survival
9%
Viral Disease
9%
Autoimmune Liver Disease
8%
Hepatitis B Virus
8%
Viral Load
8%
Survival Rate
6%
Agonist
5%
TLR7
5%
Prednisone
5%
Tenofovir
5%